Jennifer S. Allen

CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

Ania Skowera, Richard J. Ellis, Rubén Varela‐Calviño et al. · Journal of Clinical Investigation · 2008 · 361 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg white lysozyme.

Bruce A. Malcolm, Steven Rosenberg, Michael J. Corey et al. · Proceedings of the National Academy of Sciences · 1989 · 175 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

Sally Thrower, Louisa K. James, Wayne Hall et al. · Clinical & Experimental Immunology · 2008 · 151 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Plasmacytoid Dendritic Cells Are Proportionally Expanded at Diagnosis of Type 1 Diabetes and Enhance Islet Autoantigen Presentation to T-Cells Through Immune Complex Capture

Jennifer S. Allen, Karl H. Pang, Ania Skowera et al. · Diabetes · 2008 · 110 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Double mutagenesis of a positive charge cluster in the ligand-binding site of the ferric enterobactin receptor, FepA

Salete M. Newton, Jennifer S. Allen, Zhenghua Cao et al. · Proceedings of the National Academy of Sciences · 1997 · 53 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15